Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial.
Marcel H A MuskietLennart TonneijckMathijs C BunckMark H H KramerD Margriet OuwensBolette HartmannJens J HolstA H Jan DanserJaap A JolesDaniël H van RaaltePublished in: Diabetes, obesity & metabolism (2021)
In contrast to our hypothesis, compared with glimepiride, linagliptin does not reduce postprandial hyperfiltration, yet appears to increase FF after meal ingestion by increasing blood pressure or RE .